Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion type Assertion NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_head.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion description "[Recently novel non-peptidic antagonists directed against CRH-R1 or CRH-R2 have been proposed as promising agents in the treatment of depression, anxiety and eating disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_provenance.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion evidence source_evidence_literature NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_provenance.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion SIO_000772 11526468 NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_provenance.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion wasDerivedFrom befree-2016 NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_provenance.
- NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_assertion wasGeneratedBy ECO_0000203 NP328485.RABf-Re88OE8Qn-ODzBVHs778Bic5wGxBVStcFq2sw-Ps130_provenance.